J1627 is the HCPCS code for: Injection, granisetron, extended-release, 0.1 mg. In 2024, 133 providers billed J1627 1,106,236 times, with an estimated $4.8M paid by Medicare.
J1627 is a Part B drug code: Medicare pays an ASP-based rate of $3.22 per 0.1 mg (2026 Q3 ASP drug pricing file). Total payment per patient depends on the dose billed.
A billed "service" on this code is one 0.1 mg unit, not one patient visit — that's why the service counts below run high.
What Medicare actually paid per service in 2024, on average: $4.37 (observed payment across all settings and modifiers — not a fee-schedule rate).
The top 5 billers nationally, ranked by 2024 Medicare service volume.
| # | Provider | Specialty | Location | Services | Est. Medicare paid |
|---|---|---|---|---|---|
| 1 | Travis Koeneke, MD | Hematology-Oncology | Manhattan, KS | 45,400 | $199K |
| 2 | Bassam Mattar, MD | Hematology-Oncology | Wichita, KS | 31,400 | $138K |
| 3 | Dennis Moore, MD | Hematology-Oncology | Wichita, KS | 26,500 | $117K |
| 4 | Joseph Moore, MD | Hematology-Oncology | Wichita, KS | 23,400 | $103K |
| 5 | Nassim Nabbout, M.D. | Hematology-Oncology | Wichita, KS | 21,600 | $93K |
Prospect 811 answers "what is this code, what does it pay, and who bills it?" for every billable code — then filters the answer to your exact territory, with phone numbers. $79/month, no contract, 14-day refund.
Start prospecting →